Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nature Communications

• Publication date

  2014-04-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ncomms4614PMID 24717798PMCID PMC4358779
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibody Recognition of the Pandemic H 1 N 1 Influenza 1 Hemagglutinin Receptor Binding Site

  2013cited by this paper
• Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus

  2013cited by this paper
• Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

  2013cited by this paper
• Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9

  2013cited by this paper
• Human infection with a novel avian-origin influenza A (H7N9) virus.

  2013cited by this paper
• Bat-derived influenza hemagglutinin H17 does not bind canonical avian or human receptors and most likely uses a unique entry mechanism.

  2013cited by this paper
• Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities

  2013cited by this paper
• Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16

  2013cited by this paper
• Hepatitis C Virus E2 Envelope Glycoprotein Core Structure

  2013cited by this paper
• Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin

  2013cited by this paper
• A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin

  2013cited by this paper
• Update: Influenza Activity — United States, September 30, 2012–February 9, 2013

  2013cited by this paper
• Antibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site

  2013cited by this paper
• Influenza. New flu virus in China worries and confuses.

  2013cited by this paper
• A common solution to group 2 influenza virus neutralization

  2013cited by this paper
• New World Bats Harbor Diverse Influenza A Viruses

  2013cited by this paper
• Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody

  2012cited by this paper
• Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity

  2012cited by this paper
• Cross-neutralization of influenza A viruses mediated by a single antibody loop

  2012cited by this paper
• Rational immunogen design to target specific germline B cell receptors

  2012cited by this paper
• Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin

  2012cited by this paper
• Influenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses

  2012cited by this paper
• Highly Conserved Protective Epitopes on Influenza B Viruses

  2012cited by this paper
• Characterization of a high‐affinity human antibody with a disulfide bridge in the third complementarity‐determining region of the heavy chain

  2012cited by this paper
• Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing

  2012cited by this paper
• Structural insights into key sites of vulnerability on HIV‐1 Env and influenza HA

  2012cited by this paper
• A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

  2011cited by this paper
• A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

  2011cited by this paper
• Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

  2011cited by this paper
• Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin

  2011cited by this paper
• Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

  2011cited by this paper
• Naturally Occurring Antibodies in Humans Can Neutralize a Variety of Influenza Virus Strains, Including H3, H1, H2, and H5

  2011cited by this paper
• A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

  2011cited by this paper
• Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design

  2010cited by this paper
• Features and development of Coot

  2010cited by this paper
• Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

  2010cited by this paper
• Glycans on influenza hemagglutinin affect receptor binding and immune response

  2009cited by this paper
• Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

  2009cited by this paper
• Antibody Recognition of a Highly Conserved Influenza Virus Epitope

  2009cited by this paper
• MolProbity: all-atom structure validation for macromolecular crystallography

  2009cited by this paper
• Single domain antibodies: promising experimental and therapeutic tools in infection and immunity

  2009cited by this paper
• Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.

  2009cited by this paper
• The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus

  2008cited by this paper
• Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains.

  2008cited by this paper
• Phaser crystallographic software

  2007cited by this paper
• The Influenza Virus Resource at the National Center for Biotechnology Information

  2007cited by this paper
• Influenza virus pleiomorphy characterized by cryoelectron tomography

  2006cited by this paper
• Antibody elbow angles are influenced by their light chain class.

  2006cited by this paper
• Avian flu: Isolation of drug-resistant H5N1 virus

  2005cited by this paper
• MUSCLE: multiple sequence alignment with high accuracy and high throughput.

  2004cited by this paper
• Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents.

  2004cited by this paper
• Effect of the Addition of Oligosaccharides on the Biological Activities and Antigenicity of Influenza A/H3N2 Virus Hemagglutinin

  2004cited by this paper
• research papers Acta Crystallographica Section D Biological

  2003cited by this paper
• An antibody that prevents the hemagglutinin low pH fusogenic transition.

  2002cited by this paper
• Correspondence e-mail:

  2000cited by this paper
• Structure of influenza virus haemagglutinin complexed with a neutralizing antibody

  1995cited by this paper
• Satisfying hydrogen bonding potential in proteins.

  1994cited by this paper
• Structure of influenza haemagglutinin at the pH of membrane fusion

  1994cited by this paper
• Crystal structure of human immunoglobulin fragment Fab new refined at 2.0 Å esolution

  1992cited by this paper
• Efficient selection for high-expression transfectants with a novel eukaryotic vector

  1991cited by this paper
• Efficient selection for high-expression transfectants with a novel eukaryotic vector.

  1991cited by this paper
• Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid

  1988cited by this paper
• Structure of myohemerythrin in the azidomet state at 1.7/1.3 A resolution.

  1987cited by this paper
• Update: influenza activity--United States.

  1986cited by this paper
• A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody.

  1984cited by this paper
• Analytical molecular surface calculation

  1983cited by this paper
• Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

  1981cited by this paper
• Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution

  1981cited by this paper
• Electronic Reprint Biological Crystallography Phenix : a Comprehensive Python-based System for Macromolecular Structure Solution

  year unknowncited by this paper

• High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains.

  2026cites this paper
• MHC class II functions as a host-specific entry receptor for representative human and swine H3N2 influenza A viruses.

  2026cites this paper
• A Mammalian Surface Display Platform to Optimize the Antigenicity of Viral Proteins for Vaccine Design

  2026cites this paper
• Influenza hemagglutinin subtypes have different sequence constraints despite sharing extremely similar structures

  2026cites this paper
• Vaccine-induced antigenic drift of a human-origin H3N2 Influenza A virus in swine alters glycan binding and sialic acid avidity

  2025cites this paper
• Human coronavirus HKU1 neutralization by glycan receptor mimicry

  2025cites this paper
• Individual Virus Detection by Peptide-Gold Nanocluster-Assembled Artificial Binder.

  2025cites this paper
• Structural basis of broad protection against influenza virus by human antibodies targeting the neuraminidase active site via a recurring motif in CDR H3

  2025cites this paper
• Probes based on Fluorescein Derivatives for Rapid Detection of H3N2 Virus Spike Proteins without Separation

  2025cites this paper
• Structure-based Design of Chimeric Influenza Hemagglutinins to Elicit Cross-group Immunity

  2025cites this paper
• An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses

  2025cites this paper
• Soluble influenza H3 trimer proteins enhance the breadth and potency of antibody response.

  2025cites this paper
• Structural and immunological characterization of the H3 influenza hemagglutinin during antigenic drift

  2025cites this paper
• How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza

  2025cites this paper
• Deciphering the Antigenic Evolution of Seasonal Influenza A Viruses with PREDAC-Transformer: From Antigenic Clustering to Key Site Identification

  2025cites this paper
• Childhood immunological imprinting of cross-subtype antibodies targeting the hemagglutinin head domain of influenza viruses

  2025cites this paper
• Passive Immunization in the Prevention and Treatment of Viral Infections

  2025cites this paper
• Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches

  2025cites this paper
• A modular platform to display multiple hemagglutinin subtypes on a single immunogen

  2025cites this paper
• Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies

  2025cites this paper
• High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains

  2025cites this paper
• Cross-neutralizing and potent human monoclonal antibodies against historical and emerging H5Nx influenza viruses

  2025cites this paper
• Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus challenges.

  2024cites this paper
• Synthetic development of a broadly neutralizing antibody against snake venom long-chain α-neurotoxins

  2024cites this paper
• Mosaic quadrivalent influenza vaccine single nanoparticle characterization

  2024cites this paper
• Structural characterization of human monoclonal antibodies targeting uncommon antigenic sites on spike glycoprotein of SARS-CoV

  2024cites this paper
• Antibody inhibition of influenza A virus assembly and release

  2024cites this paper
• Multifaceted virus-like particles: Navigating towards broadly effective influenza A virus vaccines

  2024cites this paper
• Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutinin

  2024cites this paper
• Antigen flexibility supports the avidity of hemagglutinin-specific antibodies at low antigen densities

  2024cites this paper
• Cancer cells and viruses share common glycoepitopes: exciting opportunities toward combined treatments

  2024cites this paper
• Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variants

  2024cites this paper
• Efficiency of membrane fusion inhibitors on different hemagglutinin subtypes: insight from a molecular dynamics simulation perspective

  2024cites this paper
• Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants

  2024cites this paper
• Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies

  2023influential citation
• Computational peptide engineering approach for selection of the new C05 antibody-driven peptide with potency to blocking influenza a virus attachment; from in silico to in vivo

  2023cites this paper
• Probing altered receptor specificities of antigenically drifting human H3N2 viruses by chemoenzymatic synthesis, NMR, and modeling

  2023cites this paper
• Antigen spacing on protein nanoparticles influences antibody responses to vaccination

  2023cites this paper
• Identification of broad-spectrum neutralizing antibodies against influenza A virus and evaluation of their prophylactic efficacy in mice.

  2023cites this paper
• A class of antibodies that overcome a steric barrier to cross-group neutralization of influenza viruses

  2023cites this paper
• Analysis of the conserved protective epitopes of hemagglutinin on influenza A viruses

  2023influential citation
• Stringent and complex sequence constraints of an IGHV1–69 broadly neutralizing antibody to influenza HA stem

  2023cites this paper
• Exploiting the Affimer platform against influenza A virus

  2023cites this paper
• Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine

  2023cites this paper
• Broadly neutralizing antibodies to combat influenza virus infection.

  2023cites this paper
• Application of germline antibody features to vaccine development, antibody discovery, antibody optimization and disease diagnosis.

  2023cites this paper
• Antibody Inhibition of Influenza A Virus Assembly and Release

  2023cites this paper
• A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses

  2023cites this paper
• Antigen spacing on protein nanoparticles influences antibody responses to vaccination

  2023cites this paper
• Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses

  2023cites this paper
• Stringent and complex sequence constraints of an IGHV1-69 broadly neutralizing antibody to influenza Ha stem

  2023cites this paper
• Broad neutralizing antibody-based strategies to tackle influenza.

  2022cites this paper
• Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies

  2022cites this paper
• Human Antibodies for Viral Infections.

  2022cites this paper
• An epitope-enriched immunogen increases site targeting in germinal centers

  2022cites this paper
• Switching Heavy Chain Constant Domains Denatures the Paratope 3D Architecture of Influenza Monoclonal Antibodies

  2022cites this paper
• Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity

  2022cites this paper
• MADE: A Computational Tool for Predicting Vaccine Effectiveness for the Influenza A(H3N2) Virus Adapted to Embryonated Eggs

  2022cites this paper
• Pre-existing immunity to influenza viruses through infection and/or vaccination leads to viral mutational signatures associated with unique immune responses during a subsequent infection

  2022cites this paper
• Hierarchical sequence-affinity landscapes shape the evolution of breadth in an anti-influenza receptor binding site antibody

  2022cites this paper
• SARS-CoV-2 Antibody Effectiveness Is Influenced by Non-Epitope Mutation/Binding-Induced Denaturation of the Epitope 3D Architecture

  2022cites this paper
• An epitope-enriched immunogen expands responses to a conserved viral site

  2022cites this paper
• Influenza B: Prospects for the Development of Cross-Protective Vaccines

  2022cites this paper
• Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice

  2022cites this paper
• Emerging antiviral therapies and drugs for the treatment of influenza

  2022cites this paper
• Antibodies to combat viral infections: development strategies and progress

  2022cites this paper
• Glycoprotein molecular dynamics analysis: SARS-CoV-2 spike glycoprotein case study

  2022cites this paper
• Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses

  2022cites this paper
• Influenza Neuraminidase Characteristics and Potential as a Vaccine Target

  2021cites this paper
• The Importance of Glycosylation in COVID-19 Infection.

  2021cites this paper
• Comparison of N-linked glycosylation on hemagglutinins derived from chicken embryos and MDCK cells: a case of the production of a trivalent seasonal influenza vaccine

  2021cites this paper
• ScanNet: an interpretable geometric deep learning model for structure-based protein binding site prediction

  2021cites this paper
• Altering the Immunogenicity of Hemagglutinin Immunogens by Hyperglycosylation and Disulfide Stabilization

  2021cites this paper
• Quadrivalent influenza nanoparticle vaccines induce broad protection

  2021cites this paper
• Influenza Virus and SARS-CoV-2 Vaccines

  2021cites this paper
• B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat

  2021cites this paper
• A cross-neutralizing antibody between HIV-1 and influenza virus

  2021cites this paper
• Targeting Viral Surface Proteins through Structure-Based Design

  2021cites this paper
• Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy

  2021cites this paper
• Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic

  2021cites this paper
• Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines

  2021cites this paper
• Influence of N-glycosylation on Expression and Function of Pseudorabies Virus Glycoprotein gB

  2021cites this paper
• Understanding the Structure and Function of Viral Glycosylation by Molecular Simulations: State-of-the-Art and Recent Case Studies

  2021cites this paper
• Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19

  2021cites this paper
• University of Groningen The nature and evolution of humoral immune responses to influenza virus

  2021cites this paper
• An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain

  2020cites this paper
• Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies

  2020cites this paper
• Triple combination therapy of favipiravir plus two monoclonal antibodies eradicates influenza virus from nude mice

  2020cites this paper
• Computationally Designed Cyclic Peptides Derived from an Antibody Loop Increase Breadth of Binding for Influenza Variants.

  2020cites this paper
• Structural Biology of Influenza Hemagglutinin: An Amaranthine Adventure

  2020cites this paper
• Development of broadly reactive influenza vaccines by targeting the conserved regions of the hemagglutinin stem and head domains

  2020influential citation
• Longitudinal course of influenza C virus antibody titers of healthy adults in Sendai, Japan.

  2020cites this paper
• Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccines

  2020cites this paper
• Triple combination therapy of favipiravir plus two monoclonal antibodies eradicates influenza virus from nude mice

  2020cites this paper
• Next-Generation Influenza Vaccines.

  2020cites this paper
• Recent advances in “universal” influenza virus antibodies: the rise of a hidden trimeric interface in hemagglutinin globular head

  2020cites this paper
• A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies

  2020cites this paper
• Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

  2020cites this paper
• Major antigenic site B of human influenza H3N2 viruses has an evolving local fitness landscape

  2020cites this paper
• Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA

  2020influential citation